BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16376303)

  • 21. ARDent about acetylation and deacetylation in hypoxia signalling.
    Bilton R; Trottier E; Pouysségur J; Brahimi-Horn MC
    Trends Cell Biol; 2006 Dec; 16(12):616-21. PubMed ID: 17070052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.
    Kang J; Chun YS; Huh J; Park JW
    Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protein acetyltransferase ARD1: a novel cancer drug target?
    Arnesen T; Thompson PR; Varhaug JE; Lillehaug JR
    Curr Cancer Drug Targets; 2008 Nov; 8(7):545-53. PubMed ID: 18991565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C-δ interacts with and phosphorylates ARD1.
    Chun KH; Cho SJ; Lee JW; Seo JH; Kim KW; Lee SK
    J Cell Physiol; 2021 Jan; 236(1):379-391. PubMed ID: 32542692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of ARD1 function in hypoxia response using retroviral RNA interference.
    Fisher TS; Etages SD; Hayes L; Crimin K; Li B
    J Biol Chem; 2005 May; 280(18):17749-57. PubMed ID: 15755738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential responses of two degradation domains of HIF-1alpha to hypoxia and iron deficiency.
    Lee KH; Choi E; Chun YS; Kim MS; Park JW
    Biochimie; 2006 Feb; 88(2):163-9. PubMed ID: 16139409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.
    Arnesen T; Gromyko D; Horvli O; Fluge Ø; Lillehaug J; Varhaug JE
    Thyroid; 2005 Oct; 15(10):1131-6. PubMed ID: 16279846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
    Yoon H; Shin SH; Shin DH; Chun YS; Park JW
    Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.
    Lim JH; Park JW; Chun YS
    Cancer Res; 2006 Nov; 66(22):10677-82. PubMed ID: 17108104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Versatility of ARD1/NAA10-mediated protein lysine acetylation.
    Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH
    Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion.
    Asaumi M; Iijima K; Sumioka A; Iijima-Ando K; Kirino Y; Nakaya T; Suzuki T
    J Biochem; 2005 Feb; 137(2):147-55. PubMed ID: 15749829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning, characterization, and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse.
    Pang AL; Peacock S; Johnson W; Bear DH; Rennert OM; Chan WY
    Biol Reprod; 2009 Aug; 81(2):302-9. PubMed ID: 19246321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrest defective 1 regulates the oxidative stress response in human cells and mice by acetylating methionine sulfoxide reductase A.
    Shin SH; Yoon H; Chun YS; Shin HW; Lee MN; Oh GT; Park JW
    Cell Death Dis; 2014 Oct; 5(10):e1490. PubMed ID: 25341044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chaperone-like protein HYPK acts together with NatA in cotranslational N-terminal acetylation and prevention of Huntingtin aggregation.
    Arnesen T; Starheim KK; Van Damme P; Evjenth R; Dinh H; Betts MJ; Ryningen A; Vandekerckhove J; Gevaert K; Anderson D
    Mol Cell Biol; 2010 Apr; 30(8):1898-909. PubMed ID: 20154145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation.
    Seo JH; Cha JH; Park JH; Jeong CH; Park ZY; Lee HS; Oh SH; Kang JH; Suh SW; Kim KH; Ha JY; Han SH; Kim SH; Lee JW; Park JA; Jeong JW; Lee KJ; Oh GT; Lee MN; Kwon SW; Lee SK; Chun KH; Lee SJ; Kim KW
    Cancer Res; 2010 Jun; 70(11):4422-32. PubMed ID: 20501853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues].
    Yu M; Huang C; Xiang M; Lai J; Yang H; Ma M; Tan D
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1155-61. PubMed ID: 18837388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex.
    Arnesen T; Gromyko D; Pendino F; Ryningen A; Varhaug JE; Lillehaug JR
    Oncogene; 2006 Jul; 25(31):4350-60. PubMed ID: 16518407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.
    Kuo HP; Lee DF; Xia W; Lai CC; Li LY; Hung MC
    Biochem Biophys Res Commun; 2009 Nov; 389(1):156-61. PubMed ID: 19716809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1α Accumulation in Cancer Cells.
    Kim H; Na YR; Kim SY; Yang EG
    J Cell Biochem; 2016 Mar; 117(3):647-58. PubMed ID: 26284819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Production of anti-recombinant human arrest defective 1 protein (hARD1) monoclonal antibodies for assaying human breast cancer tissues].
    Yu M; Wang Z; Gong J; Ma M; Jiao Y; Huang W; Lü Q; Li L; Yang H; Tan D
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):57-62. PubMed ID: 20353093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.